CHRISTINA GREISLER: Open Payments
NPI 1386052710 · ROCKY HILL, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,183 in 199 payments from 18 companies in 2025. Trend: 2023 $3,316 · 2024 $3,155 · 2025 $4,183
Food & beverage: $4,174Education: $10
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 49 | $864 |
| LEO Pharma Inc. | 16 | $410 |
| UCB, Inc. | 14 | $381 |
| Amgen Inc. | 11 | $348 |
| PFIZER INC. | 14 | $332 |
| Janssen Biotech, Inc. | 12 | $308 |
| Galderma Laboratories, L.P. | 6 | $288 |
| Lilly USA, LLC | 17 | $249 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 14 | $248 |
| Arcutis Biotherapeutics, Inc. | 11 | $152 |
Products named: RINVOQ, Bimzelx, ADBRY, Otezla, CIBINQO, TREMFYA, NEMLUVIO, TALTZ.
Industry payments across CT — which companies pay providers there.
